Eva Barragán

3.9k total citations
92 papers, 1.7k citations indexed

About

Eva Barragán is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eva Barragán has authored 92 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 54 papers in Molecular Biology and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eva Barragán's work include Acute Myeloid Leukemia Research (59 papers), Acute Lymphoblastic Leukemia research (24 papers) and Retinoids in leukemia and cellular processes (23 papers). Eva Barragán is often cited by papers focused on Acute Myeloid Leukemia Research (59 papers), Acute Lymphoblastic Leukemia research (24 papers) and Retinoids in leukemia and cellular processes (23 papers). Eva Barragán collaborates with scholars based in Spain, United Kingdom and Italy. Eva Barragán's co-authors include Miguel Á. Sanz, Pascual Bolufer, José Cervera, Guillermo Martı́n, Esperanza Such, Mariam Ibáñez, Pascual Fernández, Guillermo Sanz, Ana Valencia and Federico Moscardó and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Eva Barragán

88 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva Barragán Spain	24	1.1k	936	395	283	251	92	1.7k
Pascual Bolufer Spain	23	1.4k 1.3×	1.2k 1.3×	503 1.3×	245 0.9×	184 0.7×	65	2.0k
F Viguié France	21	861 0.8×	844 0.9×	327 0.8×	273 1.0×	206 0.8×	45	1.6k
Sanne Lugthart Netherlands	14	1.3k 1.2×	1.4k 1.5×	325 0.8×	388 1.4×	349 1.4×	26	2.0k
Philippe Rousselot France	20	799 0.7×	870 0.9×	269 0.7×	243 0.9×	109 0.4×	44	1.5k
Sébastien Malinge United States	17	631 0.6×	611 0.7×	323 0.8×	308 1.1×	191 0.8×	33	1.4k
Christian Flotho Germany	23	974 0.9×	883 0.9×	242 0.6×	356 1.3×	160 0.6×	62	1.6k
Manoj Raghavan United Kingdom	17	734 0.7×	910 1.0×	308 0.8×	267 0.9×	267 1.1×	45	1.7k
Heiko Becker Germany	19	1.1k 1.0×	1.1k 1.2×	243 0.6×	423 1.5×	519 2.1×	59	1.9k
Ulrike Schäkel Germany	12	852 0.8×	1.7k 1.8×	450 1.1×	617 2.2×	157 0.6×	15	2.0k
Mikael Behrendtz Sweden	22	679 0.6×	639 0.7×	837 2.1×	136 0.5×	183 0.7×	40	1.6k

Countries citing papers authored by Eva Barragán

Since Specialization

Citations

This map shows the geographic impact of Eva Barragán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Barragán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Barragán more than expected).

Fields of papers citing papers by Eva Barragán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Barragán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Barragán. The network helps show where Eva Barragán may publish in the future.

Co-authorship network of co-authors of Eva Barragán

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Barragán. A scholar is included among the top collaborators of Eva Barragán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Barragán. Eva Barragán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sargas, Claudia, Marta Llop, Rebeca Rodríguez‐Veiga, et al.. (2025). Feasible and Rapid Screening of IDH1/2 and FLT3-TKD2 Mutations by High-Resolution Melting for Patients with Acute Myeloid Leukemia. Diagnostics. 15(10). 1230–1230.

Avetisyan, Gayane, António A. Vicente, Rafael Andreu, et al.. (2025). Benchmarking standard-of-care and emerging genomic approaches to enhance diagnosis in pediatric acute lymphoblastic leukemia. British Journal of Cancer. 133(11). 1744–1754.

Gil, José Vicente, Esperanza Such, Claudia Sargas, et al.. (2023). Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 24(5). 4440–4440. 6 indexed citations

Barragán, Eva, Esperanza Such, Cristina Gil, et al.. (2022). Identification of Leukemia-Associated Immunophenotypes by Databaseguided Flow Cytometry Provides a Highly Sensitive and Reproducible Strategy for the Study of Measurable Residual Disease in Acute Myeloblastic Leukemia. Cancers. 14(16). 4010–4010. 9 indexed citations

Liquori, Alessandro, Mariam Ibáñez, Claudia Sargas, et al.. (2021). Correction: Liquori et al. Acute Promyelocytic Leukemia: A Constellation of Molecular Events around a Single PML-RARA Fusion Gene. Cancers 2020, 12, 624. Cancers. 13(14). 3440–3440. 1 indexed citations

Megías‐Vericat, Juan Eduardo, et al.. (2020). Tyrosine kinase inhibitors for acute myeloid leukemia: A step toward disease control?. Blood Reviews. 44. 100675–100675. 21 indexed citations

Bodega‐Mayor, Irene, Francisca Molina‐Jiménez, Martín González‐Andrade, et al.. (2020). TYK2 Variants in B-Acute Lymphoblastic Leukaemia. Genes. 11(12). 1434–1434. 7 indexed citations

Mannan, Abdul, Ibrahim N. Muhsen, Eva Barragán, et al.. (2020). Genotypic and Phenotypic Characteristics of Acute Promyelocytic Leukemia Translocation Variants. Hematology/Oncology and Stem Cell Therapy. 13(4). 189–201. 25 indexed citations

Stella, Stefania, Eva Barragán, Santa Errichiello, et al.. (2019). The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias. International Journal of Molecular Sciences. 20(24). 6106–6106. 10 indexed citations

10.

Llop, Marta, Eva Barragán, Begoña Laíz, et al.. (2019). Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital. Cancers. 11(8). 1196–1196. 17 indexed citations

11.

Ibáñez, Mariam, José Carbonell‐Caballero, Esperanza Such, et al.. (2018). The modular network structure of the mutational landscape of Acute Myeloid Leukemia. PLoS ONE. 13(10). e0202926–e0202926. 5 indexed citations

12.

Niveiro, Marı́a, M Tasso, Francisco López, et al.. (2017). A Rare Case of Pure Erythroid Sarcoma in a Pediatric Patient: Case Report and Literature Review. Children. 4(12). 113–113. 8 indexed citations

13.

Palanca, Sarai, Eva Barragán, Isabel Chirivella, et al.. (2012). The deletion of exons 3–5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families. Familial Cancer. 12(1). 119–123. 8 indexed citations

14.

Ibáñez, Mariam, Esperanza Such, José Cervera, et al.. (2012). Rapid Screening of ASXL1, IDH1, IDH2, and c-CBL Mutations in de Novo Acute Myeloid Leukemia by High-Resolution Melting. Journal of Molecular Diagnostics. 14(6). 594–601. 14 indexed citations

15.

Valencia, Ana, José Cervera, Esperanza Such, et al.. (2010). A new reliable fluorescencein situhybridization method for identifying multiple specific cytogenetic abnormalities in acute myeloid leukemia. Leukemia & lymphoma. 51(4). 680–685. 1 indexed citations

16.

Bolufer, Pascual, et al.. (2006). Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leukemia Research. 30(12). 1471–1491. 76 indexed citations

17.

Bolufer, Pascual, Eva Barragán, Amparo Verdeguer, et al.. (2002). Rapid quantitative detection of TEL-AML1 fusion transcripts in pediatric acute lymphoblastic leukemia by real-time reverse transcription polymerase chain reaction using fluorescently labeled probes.. PubMed. 87(1). 23–32. 8 indexed citations

18.

López‐Guerrero, José Antonio, et al.. (1999). Use of Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR) for Carcinoembryonic Antigen, Cytokeratin 19, and Maspin in the Detection of Tumor Cells in Leukapheresis Products from Patients with Breast Cancer: Comparison with Immunocytochemistry. Journal of Hematotherapy. 8(1). 53–61. 28 indexed citations

19.

Solves, Pilar, Pascual Bolufer, Eva Barragán, et al.. (1999). Chronic myeloid leukemia with expression of ALL-type BCR/ABL transcript: a case-report and review of the literature. Leukemia Research. 23(9). 851–854. 5 indexed citations

20.

Barragán, Eva, et al.. (1998). Comparison of Two Reverse Transcription-Polymerase Chain Reaction Methods for Detection of AML1/ETO Rearrangement in the M2 Subtype of Acute Myeloid Leukaemia. Clinical Chemistry and Laboratory Medicine (CCLM). 36(3). 137–142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact